Skip to main content

AMGEN INC

For the period ended Jun 30, 2024. Filed Aug 7, 2024.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jun 30, 2024 · Filed Aug 7, 2024

AMGN$465.230.0%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

CONDENSED CONSOLIDATED STATEMENTS OF INCOME

Three months endedJune 30,Six months endedJune 30,
2024202320242023
Revenues:
Product sales$8,041$6,683$15,159$12,529
Other revenues347303676562
Total revenues8,3886,98615,83513,091
Operating expenses:
Cost of sales3,2361,8136,4363,533
Research and development1,4471,1132,7902,171
Selling, general and administrative1,7851,2943,5932,552
Other1182116230
Total operating expenses6,4794,30212,9358,486
Operating income1,9092,6842,9004,605
Other income (expense):
Interest expense, net(808)(752)(1,632)(1,295)
Other (expense) income, net(307)(318)(542)1,746
Income before income taxes7941,6147265,056
Provision for income taxes4823593836
Net income$746$1,379$633$4,220
Earnings per share:
Basic$1.39$2.58$1.18$7.90
Diluted$1.38$2.57$1.17$7.86
Shares used in calculation of earnings per share:
Basic537535537534
Diluted541537541537
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.